Finally, in the third, cathepsin-B (Figure 2C) was able to discriminate 12 lymphomas with high ADA levels from 12 TB with 100% sensitivity (95% CI 73.5–100%) and 83.3% specificity (95% CI 51.6–98%). This evidence concerns the gene CTSB and lymphoma.